Vista Pharmaceuticals Limited (BOM:524711)
India
· Delayed Price · Currency is INR 6.24
+0.15 (2.46%)
At close: Mar 10, 2026
Vista Pharmaceuticals Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2020 - 2016 |
| Net Income | - | -46.49 | -45.12 | -56.62 | -8.89 | -20.09 | Upgrade
|
| Depreciation & Amortization | - | 7.38 | 7.2 | 6.18 | 6.16 | 7.28 | Upgrade
|
| Loss (Gain) From Sale of Investments | - | 0.25 | 0.04 | -0.14 | - | -0.24 | Upgrade
|
| Other Operating Activities | - | -1.03 | 5.54 | 20.63 | -8.39 | -1.3 | Upgrade
|
| Change in Accounts Receivable | - | 7.37 | -30.31 | -7.87 | -4.02 | 81.11 | Upgrade
|
| Change in Inventory | - | -14.34 | 8.91 | 16.51 | 3.54 | - | Upgrade
|
| Change in Accounts Payable | - | -18.1 | -3.97 | 24.36 | 2.62 | -43.21 | Upgrade
|
| Change in Other Net Operating Assets | - | -4.88 | 8.58 | -20.16 | -0.95 | -91.01 | Upgrade
|
| Operating Cash Flow | - | -69.85 | -49.14 | -17.11 | -9.93 | -67.47 | Upgrade
|
| Capital Expenditures | - | -4.4 | -7.9 | -12.7 | -0.14 | -2.99 | Upgrade
|
| Investing Cash Flow | - | -4.4 | -7.9 | -12.7 | -0.14 | -2.99 | Upgrade
|
| Short-Term Debt Issued | - | - | 7.97 | - | - | - | Upgrade
|
| Long-Term Debt Issued | - | - | - | - | 6.74 | 31.86 | Upgrade
|
| Total Debt Issued | - | - | 7.97 | - | 6.74 | 31.86 | Upgrade
|
| Short-Term Debt Repaid | - | -0.07 | - | -3.46 | - | - | Upgrade
|
| Long-Term Debt Repaid | - | -5.53 | -22.47 | -22.47 | - | - | Upgrade
|
| Total Debt Repaid | - | -5.6 | -22.47 | -25.92 | - | - | Upgrade
|
| Net Debt Issued (Repaid) | - | -5.6 | -14.5 | -25.92 | 6.74 | 31.86 | Upgrade
|
| Issuance of Common Stock | - | 143.87 | 96.08 | 7.63 | - | 90 | Upgrade
|
| Other Financing Activities | - | -57.63 | -25.64 | 49.43 | 2.65 | -52.26 | Upgrade
|
| Financing Cash Flow | - | 80.64 | 55.94 | 31.14 | 9.39 | 69.61 | Upgrade
|
| Miscellaneous Cash Flow Adjustments | - | - | - | 0 | -0 | -0 | Upgrade
|
| Net Cash Flow | - | 6.39 | -1.1 | 1.32 | -0.68 | -0.85 | Upgrade
|
| Free Cash Flow | - | -74.25 | -57.04 | -29.82 | -10.07 | -70.46 | Upgrade
|
| Free Cash Flow Margin | - | -73.70% | -55.44% | -297.07% | -255.34% | -556.35% | Upgrade
|
| Free Cash Flow Per Share | - | -1.26 | -1.31 | -0.81 | -0.27 | -2.03 | Upgrade
|
| Cash Interest Paid | - | 9.64 | 12.2 | 12.14 | 9 | 15.49 | Upgrade
|
| Cash Income Tax Paid | - | 4.3 | - | -10.53 | - | - | Upgrade
|
| Levered Free Cash Flow | - | -61.1 | 72.14 | -25.52 | -92.08 | 50.57 | Upgrade
|
| Unlevered Free Cash Flow | - | -55.33 | 79.86 | -17.34 | -86.47 | 60.22 | Upgrade
|
| Change in Working Capital | - | -29.95 | -16.79 | 12.84 | 1.19 | -53.11 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.